Young Astrocytic Mitochondria Attenuate the Elevated Level of CCL11 in the Aged Mice, Contributing to Cognitive Function Improvement

Int J Mol Sci. 2023 Mar 8;24(6):5187. doi: 10.3390/ijms24065187.

Abstract

Aging drives cognitive decline, and mitochondrial dysfunction is a hallmark of age-induced neurodegeneration. Recently, we demonstrated that astrocytes secrete functional mitochondria (Mt), which help adjacent cells to resist damage and promote repair after neurological injuries. However, the relationship between age-dependent changes in astrocytic Mt function and cognitive decline remains poorly understood. Here, we established that aged astrocytes secret less functional Mt compared to young astrocytes. We found the aging factor C-C motif chemokine 11 (CCL11) is elevated in the hippocampus of aged mice, and that its level is reduced upon systemic administration of young Mt, in vivo. Aged mice receiving young Mt, but not aged Mt improved cognitive function and hippocampal integrity. Using a CCL11-induced aging-like model in vitro, we found that astrocytic Mt protect hippocampal neurons and enhance a regenerative environment through upregulating synaptogenesis-related gene expression and anti-oxidants that were suppressed by CCL11. Moreover, the inhibition of CCL11-specific receptor C-C chemokine receptor 3 (CCR3) boosted the expression of synaptogenesis-related genes in the cultured hippocampal neurons and restored the neurite outgrowth. This study suggests that young astrocytic Mt can preserve cognitive function in the CCL11-mediated aging brain by promoting neuronal survival and neuroplasticity in the hippocampus.

Keywords: CCL11; aging; astrocytes; cognition; hippocampus; mitochondria; neuroplasticity.

MeSH terms

  • Animals
  • Astrocytes* / metabolism
  • Brain / metabolism
  • Chemokine CCL11 / metabolism
  • Cognition
  • Hippocampus / metabolism
  • Mice
  • Mitochondria / metabolism
  • Neurons* / metabolism

Substances

  • Ccl11 protein, mouse
  • Chemokine CCL11

Grants and funding

This project was supported by UTHealth startup funding to J.E.J.